Tumor organoids have been established as a powerful tool for studying tumor heterogeneity.[12] Therefore, we developed a novel patient‐derived meningioma organoid (MO) model to further characterize the MC SULT1E1+ subpopulation. The gene discussed is SULT1E1; the disease is meningioma.